A detailed history of Prestige Wealth Management Group LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Prestige Wealth Management Group LLC holds 379 shares of NVO stock, worth $33,113. This represents 0.01% of its overall portfolio holdings.

Number of Shares
379
Previous 379 -0.0%
Holding current value
$33,113
Previous $54,000 16.67%
% of portfolio
0.01%
Previous 0.01%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Apr 26, 2024

SELL
$87.78 - $105.45 $1,316 - $1,581
-15 Reduced 3.81%
379 $39,000
Q4 2023

Feb 08, 2024

SELL
$87.78 - $105.45 $1,316 - $1,581
-15 Reduced 3.81%
379 $39,000
Q3 2023

Apr 26, 2024

BUY
$90.94 - $199.54 $17,915 - $39,309
197 Added 100.0%
394 $35,000
Q3 2023

Nov 13, 2023

BUY
$90.94 - $199.54 $17,915 - $39,309
197 Added 100.0%
394 $35,000
Q1 2023

Apr 26, 2024

SELL
$132.34 - $159.14 $24,085 - $28,963
-182 Reduced 48.02%
197 $31,000
Q1 2023

May 16, 2023

SELL
$132.34 - $159.14 $8,337 - $10,025
-63 Reduced 24.23%
197 $31,000
Q4 2022

Feb 07, 2023

BUY
$102.55 - $135.33 $2,666 - $3,518
26 Added 11.11%
260 $35,000
Q3 2022

Nov 01, 2022

SELL
$95.28 - $116.93 $762 - $935
-8 Reduced 3.31%
234 $23,000
Q1 2021

May 13, 2021

SELL
$67.06 - $75.82 $2,615 - $2,956
-39 Reduced 13.88%
242 $16,000
Q4 2020

Feb 17, 2021

SELL
$63.89 - $73.8 $702 - $811
-11 Reduced 3.77%
281 $20,000
Q2 2020

Aug 13, 2020

SELL
$58.54 - $67.94 $292 - $339
-5 Reduced 1.68%
292 $19,000
Q1 2020

May 15, 2020

BUY
$49.46 - $64.78 $14,442 - $18,915
292 Added 5840.0%
297 $18,000
Q3 2019

Nov 14, 2019

BUY
$47.54 - $53.43 $237 - $267
5 New
5 $0
Q2 2019

Aug 16, 2019

SELL
$46.79 - $52.47 $17,920 - $20,096
-383 Closed
0 $0
Q1 2019

Aug 16, 2019

SELL
$46.36 - $52.63 $3,291 - $3,736
-71 Reduced 15.64%
383 $20,000
Q4 2018

Apr 16, 2019

BUY
$41.54 - $47.25 $18,859 - $21,451
454 New
454 $21,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Prestige Wealth Management Group LLC Portfolio

Follow Prestige Wealth Management Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prestige Wealth Management Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prestige Wealth Management Group LLC with notifications on news.